Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility

The United States Food and Drug Administration (USFDA) had conducted Pre-Approval Inspection (PAI) of Emcure Pharmaceuticals Limited's manufacturing facility (Oncology) located at G.I.D.C., Taluka - Sanand, Ahmedabad from June 30, 2025 to July 08, 2025. The inspection concluded without issuance of Form 483 (zero observations).

Gland Pharma receives GMP compliance from Danish Medicines Agency

The Pashamylaram facility of Gland Pharma Limited has received certificate of Good Manufacturing Practices (GMP) compliance from Danish Medicines Agency in connection with Marketing authorizations listing manufacturers located outside of the European Economic Area, for aseptically prepared Powder for injection, infusion and inhalation.